Leading health law firm Hill Dickinson has entered into a partnership agreement with Medilink North of England Ltd, the representative body for the healthcare technology sector, as part of its strategy to promote the firm’s fast-growing and specialist capability in healthtech and life sciences.
The three-year agreement was announced at Medilink’s Global Medical Device & IVD Regulations conference on Tuesday 9 July, which was held in Hill Dickinson’s Liverpool office.
The agreement sees Hill Dickinson become a corporate partner of Medilink and the exclusively recommended provider of legal services to Medilink’s North of England network of members, spin out companies and inward investors.
James Lawford Davies, a partner at Hill Dickinson, whose specialism is life science regulation and litigation, said:
“Entering into a new partnership with Medilink North of England is a reflection of our commitment to life sciences and health technologies. We’re delighted to be working with Kevin and his team, and we look forward to getting to know their member companies and helping them take their products to market in the UK and beyond.”
He added:
“The healthtech and life sciences sectors span a huge range of rapidly advancing technologies and these are markets we know and understand well. This knowledge, together with our multidisciplinary approach to navigating the often-complex legal issues that can arise when dealing with new technologies, means we are able to handle sector-specific, as well as commercial, IP and all related aspects of a project under one roof.”
Kevin Kiely, chief executive of Medilink said:
“”We are really pleased to announce our partnership with Hill Dickinson, to provide our members with a first rate legal service with a difference – a culture within the firm of genuinely wanting to help businesses to succeed, not just through the provision of commercial legal services but also through advice on investment and regulation. With a shared ethos, we look forward to working with Hill Dickinson to add real value to members.”
As part of the deal, Hill Dickinson will have a dedicated micro site on the Medilink web portal, allowing enquirers direct access to advice and services from the firm and its growing team of healthtech and life sciences experts. These include:
Rob McGough, Head of Commercial Health, and specialist in providing advice on development of strategic priorities and new and innovative ways of delivering care.
Michael Bennett, Head of Corporate and Commercial (London), advising clients on flotations, reverse takeovers, placings, open offers and dual listings. Michael and his team recently worked on the interpretation and application of the laws in the UK in relation to medicinal cannabis and advised on the first medical cannabis investments by a UK listed company on AIM and on the first medical cannabis IPO in the UK since 2001.
Michael Corcoran, Corporate Partner, working primarily with high growth private companies and companies with relatively small market capitalisation, including in the life sciences and technology sectors.
James Lawford Davies, Partner, specialising in life sciences and healthtech regulation and litigation, with a particular interest in advanced therapies, tissue and cell based therapies, and devices.
Jamie Foster, Partner and Corporate Commercial Lawyer, specialising in the health and life sciences sectors including advising clients on commercial and regulatory frameworks for healthtech, medtech and biotech start ups
Prof Nils Hoppe, Consultant, specialist in life sciences and healthtech, with particular expertise in biobanking, cell and gene based technologies, regenerative medicine and bioethics
News & Analysis
Share:
